Tsuneyasu Kaisho is a prominent inventor based in Hyogo, Japan. He has made significant contributions to the field of immunology, particularly in the development of proteins that support pre-B cell growth. With a total of 7 patents to his name, his work has the potential to impact clinical diagnostics and therapeutic approaches.

Latest Patents

Kaisho's latest patents include groundbreaking inventions such as an antibody reactive with a protein that has pre-B cell growth-supporting ability. He has also developed a gene encoding a novel membrane protein polypeptide that supports pre-B cell growth. This invention includes a method for producing the membrane protein by transforming a host cell with a vector containing the gene and culturing the resulting transformants. Additionally, he has created a monoclonal antibody that recognizes this membrane protein. The homogeneous and purified novel membrane protein polypeptide can be produced in large quantities, which is useful for generating monoclonal antibodies that aid in identifying rheumatoid arthritis and preparing clinical diagnostic reagents.

Career Highlights

Throughout his career, Tsuneyasu Kaisho has focused on advancing the understanding of pre-B cell growth and its implications in health and disease. His innovative approaches have led to significant advancements in the field, showcasing his dedication to research and development.

Collaborations

Kaisho has collaborated with notable professionals in his field, including Toshio Hirano. These partnerships have further enhanced the impact of his research and inventions.

Conclusion

Tsuneyasu Kaisho's contributions to the field of immunology through his patents and research are noteworthy. His work on pre-B cell growth-supporting proteins holds promise for future advancements in clinical diagnostics and therapeutic interventions.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]